CA Stock MarketDetailed Quotes

LABS MediPharm Labs Corp

Watchlist
  • 0.070
  • +0.005+7.69%
15min DelayMarket Closed Nov 29 16:00 ET
28.78MMarket Cap-2333P/E (TTM)

MediPharm Labs Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
79.52%-662K
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
-21.62%-16.07M
95.85%-168K
Net income from continuing operations
35.89%-2.77M
10.34%-2.58M
-16.94%-3.61M
56.37%-13.08M
50.31%-2.79M
45.44%-4.33M
67.94%-2.88M
58.59%-3.09M
45.29%-29.98M
74.23%-5.61M
Operating gains losses
-94.74%2K
-108.90%-21K
-6,480.00%-319K
-70.47%269K
-100.91%-10K
103.16%38K
-82.28%236K
101.58%5K
131.31%911K
540.56%1.1M
Depreciation and amortization
-16.05%518K
5.64%731K
61.22%790K
-12.40%2.52M
32.78%717K
-18.17%617K
-8.83%692K
-40.17%490K
-49.01%2.87M
-77.34%540K
Asset impairment expenditure
-110.20%-31K
-83.60%166K
--234K
27.76%1.75M
138.52%433K
-84.58%304K
--1.01M
--0
-89.40%1.37M
-116.87%-1.12M
Remuneration paid in stock
--0
82.76%-80K
101.49%23K
-1,534.33%-1.92M
129.81%48K
-86.44%40K
---464K
---1.55M
-98.03%134K
-102.61%-161K
Remuneration paid in stock
-58.55%160K
-2.04%576K
19.81%895K
-29.42%2.03M
-77.99%306K
139.75%386K
1.38%588K
0.81%747K
19.57%2.87M
127.50%1.39M
Other non cashItems
137.07%585K
103.48%180K
73.06%-66K
-1,420.70%-7.35M
-46.64%-349K
-1,260.34%-1.58M
-6,208.54%-5.17M
-421.28%-245K
-104.70%-483K
4.03%-238K
Change In working capital
-31.83%878K
62.66%-575K
-9.90%528K
-44.70%3.45M
-20.85%3.12M
-59.47%1.29M
-0.33%-1.54M
-11.08%586K
-1.83%6.24M
65.49%3.94M
-Change in receivables
-105.65%-473K
-64.56%319K
-2,700.00%-616K
77.74%6.42M
318.87%5.77M
-314.95%-230K
1,204.35%900K
-101.07%-22K
-64.55%3.61M
-79.71%1.38M
-Change in inventory
-90.08%221K
107.68%37K
-106.68%-80K
3,123.30%3.11M
-85.48%171K
21.96%2.23M
78.05%-482K
231.50%1.2M
-104.14%-103K
18.75%1.18M
-Change in payables and accrued expense
146.04%553K
68.43%-601K
336.68%1.88M
-446.48%-5.17M
-269.80%-1.27M
-439.27%-1.2M
-535.70%-1.9M
-1,668.89%-796K
118.39%1.49M
119.99%745K
-Change in other current assets
-53.28%377K
-37.65%-819K
59.00%159K
-160.89%-1.07M
-291.93%-1.38M
-30.61%807K
-54.15%-595K
-61.24%100K
152.01%1.75M
3.30%719K
-Change in other current liabilities
----
----
----
129.13%150K
----
----
----
----
-147.12%-515K
-126.95%-83K
-Change in other working capital
163.49%200K
----
-872.64%-819K
----
----
---315K
----
--106K
----
----
Cash from discontinued investing activities
Operating cash flow
79.52%-662K
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
-21.62%-16.07M
95.85%-168K
Investing cash flow
Cash flow from continuing investing activities
-102.01%-33K
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
14,637.14%5.16M
1,937.50%5.71M
Capital expenditure reported
87.31%-33K
16.42%-56K
16.00%-21K
45.42%-471K
61.49%-119K
17.72%-260K
28.72%-67K
82.64%-25K
-10.22%-863K
-50.00%-309K
Net PPE purchase and sale
--0
--21K
--326K
--178K
2,642.86%178K
--0
--0
--0
--0
66.67%-7K
Net business purchase and sale
--0
----
----
-12.50%5.26M
-29.35%4.25M
--0
----
----
--6.01M
--6.01M
Net other investing changes
----
--0
--220K
27,085.71%1.9M
--0
--1.9M
----
----
-98.62%7K
----
Cash from discontinued investing activities
Investing cash flow
-102.01%-33K
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
14,637.14%5.16M
1,937.50%5.71M
Financing cash flow
Cash flow from continuing financing activities
-643.14%-2.22M
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
-97.14%796K
-40,000.00%-399K
Net issuance payments of debt
-477.84%-2.24M
-40.40%596K
76.91%-269K
-340.20%-944K
27.32%-391K
-40.07%-388K
-21.26%1M
-1,779.03%-1.17M
113.27%393K
-564.20%-538K
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Interest paid (cash flow from financing activities)
-75.29%-149K
-13.27%-111K
-425.00%-21K
-915.38%-264K
-196.15%-77K
-4,350.00%-85K
-4,800.00%-98K
---4K
-116.67%-26K
---26K
Net other financing activities
-2.87%169K
5.82%200K
-10.40%224K
95.80%840K
37.58%227K
31.82%174K
125.00%189K
420.83%250K
408.63%429K
75.53%165K
Cash from discontinued financing activities
Financing cash flow
-643.14%-2.22M
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
-97.14%796K
-40,000.00%-399K
Net cash flow
Beginning cash position
8.47%15.99M
-16.00%16.93M
-25.53%17.98M
-29.21%24.15M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
-29.21%24.15M
71.30%34.11M
-48.75%19.45M
Current changes in cash
-54.50%-2.92M
82.60%-956K
73.29%-1.07M
42.31%-5.84M
7.84%5.54M
43.57%-1.89M
10.64%-5.49M
30.64%-4M
-169.16%-10.12M
236.50%5.14M
Effect of exchange rate changes
-81.25%18K
-75.29%21K
--12K
-319.33%-329K
-14.09%-510K
-88.12%96K
163.43%85K
--0
134.97%150K
-432.14%-447K
End cash Position
1.10%13.09M
8.47%15.99M
-16.00%16.93M
-25.53%17.98M
-25.53%17.98M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
-29.21%24.15M
-29.21%24.15M
Free cash from
80.10%-695K
78.12%-1.66M
49.71%-1.55M
24.34%-12.81M
384.07%1.36M
-9.02%-3.49M
-1.21%-7.6M
46.47%-3.08M
-20.98%-16.93M
88.78%-477K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 79.52%-662K78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M-21.62%-16.07M95.85%-168K
Net income from continuing operations 35.89%-2.77M10.34%-2.58M-16.94%-3.61M56.37%-13.08M50.31%-2.79M45.44%-4.33M67.94%-2.88M58.59%-3.09M45.29%-29.98M74.23%-5.61M
Operating gains losses -94.74%2K-108.90%-21K-6,480.00%-319K-70.47%269K-100.91%-10K103.16%38K-82.28%236K101.58%5K131.31%911K540.56%1.1M
Depreciation and amortization -16.05%518K5.64%731K61.22%790K-12.40%2.52M32.78%717K-18.17%617K-8.83%692K-40.17%490K-49.01%2.87M-77.34%540K
Asset impairment expenditure -110.20%-31K-83.60%166K--234K27.76%1.75M138.52%433K-84.58%304K--1.01M--0-89.40%1.37M-116.87%-1.12M
Remuneration paid in stock --082.76%-80K101.49%23K-1,534.33%-1.92M129.81%48K-86.44%40K---464K---1.55M-98.03%134K-102.61%-161K
Remuneration paid in stock -58.55%160K-2.04%576K19.81%895K-29.42%2.03M-77.99%306K139.75%386K1.38%588K0.81%747K19.57%2.87M127.50%1.39M
Other non cashItems 137.07%585K103.48%180K73.06%-66K-1,420.70%-7.35M-46.64%-349K-1,260.34%-1.58M-6,208.54%-5.17M-421.28%-245K-104.70%-483K4.03%-238K
Change In working capital -31.83%878K62.66%-575K-9.90%528K-44.70%3.45M-20.85%3.12M-59.47%1.29M-0.33%-1.54M-11.08%586K-1.83%6.24M65.49%3.94M
-Change in receivables -105.65%-473K-64.56%319K-2,700.00%-616K77.74%6.42M318.87%5.77M-314.95%-230K1,204.35%900K-101.07%-22K-64.55%3.61M-79.71%1.38M
-Change in inventory -90.08%221K107.68%37K-106.68%-80K3,123.30%3.11M-85.48%171K21.96%2.23M78.05%-482K231.50%1.2M-104.14%-103K18.75%1.18M
-Change in payables and accrued expense 146.04%553K68.43%-601K336.68%1.88M-446.48%-5.17M-269.80%-1.27M-439.27%-1.2M-535.70%-1.9M-1,668.89%-796K118.39%1.49M119.99%745K
-Change in other current assets -53.28%377K-37.65%-819K59.00%159K-160.89%-1.07M-291.93%-1.38M-30.61%807K-54.15%-595K-61.24%100K152.01%1.75M3.30%719K
-Change in other current liabilities ------------129.13%150K-----------------147.12%-515K-126.95%-83K
-Change in other working capital 163.49%200K-----872.64%-819K-----------315K------106K--------
Cash from discontinued investing activities
Operating cash flow 79.52%-662K78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M-21.62%-16.07M95.85%-168K
Investing cash flow
Cash flow from continuing investing activities -102.01%-33K-103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K14,637.14%5.16M1,937.50%5.71M
Capital expenditure reported 87.31%-33K16.42%-56K16.00%-21K45.42%-471K61.49%-119K17.72%-260K28.72%-67K82.64%-25K-10.22%-863K-50.00%-309K
Net PPE purchase and sale --0--21K--326K--178K2,642.86%178K--0--0--0--066.67%-7K
Net business purchase and sale --0---------12.50%5.26M-29.35%4.25M--0----------6.01M--6.01M
Net other investing changes ------0--220K27,085.71%1.9M--0--1.9M---------98.62%7K----
Cash from discontinued investing activities
Investing cash flow -102.01%-33K-103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K14,637.14%5.16M1,937.50%5.71M
Financing cash flow
Cash flow from continuing financing activities -643.14%-2.22M-37.21%685K92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K-97.14%796K-40,000.00%-399K
Net issuance payments of debt -477.84%-2.24M-40.40%596K76.91%-269K-340.20%-944K27.32%-391K-40.07%-388K-21.26%1M-1,779.03%-1.17M113.27%393K-564.20%-538K
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Interest paid (cash flow from financing activities) -75.29%-149K-13.27%-111K-425.00%-21K-915.38%-264K-196.15%-77K-4,350.00%-85K-4,800.00%-98K---4K-116.67%-26K---26K
Net other financing activities -2.87%169K5.82%200K-10.40%224K95.80%840K37.58%227K31.82%174K125.00%189K420.83%250K408.63%429K75.53%165K
Cash from discontinued financing activities
Financing cash flow -643.14%-2.22M-37.21%685K92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K-97.14%796K-40,000.00%-399K
Net cash flow
Beginning cash position 8.47%15.99M-16.00%16.93M-25.53%17.98M-29.21%24.15M-33.43%12.95M-32.97%14.74M-28.73%20.15M-29.21%24.15M71.30%34.11M-48.75%19.45M
Current changes in cash -54.50%-2.92M82.60%-956K73.29%-1.07M42.31%-5.84M7.84%5.54M43.57%-1.89M10.64%-5.49M30.64%-4M-169.16%-10.12M236.50%5.14M
Effect of exchange rate changes -81.25%18K-75.29%21K--12K-319.33%-329K-14.09%-510K-88.12%96K163.43%85K--0134.97%150K-432.14%-447K
End cash Position 1.10%13.09M8.47%15.99M-16.00%16.93M-25.53%17.98M-25.53%17.98M-33.43%12.95M-32.97%14.74M-28.73%20.15M-29.21%24.15M-29.21%24.15M
Free cash from 80.10%-695K78.12%-1.66M49.71%-1.55M24.34%-12.81M384.07%1.36M-9.02%-3.49M-1.21%-7.6M46.47%-3.08M-20.98%-16.93M88.78%-477K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data